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ABSTRACT 
Hyperlipidemia is a lipoprotein metabolic disorder characterized by high serum Low density 
Lipoprotein and blood cholesterol. It is a major risk factors in the development and 
progression of atherosclerosis that eventually lead to cardiovascular diseases. This poses a 
major problem to majority of society because of the close correlation between cardiovascular 
diseases and lipid abnormalities. There are various features which are associated directly or 
indirectly as etiological factors viz. heredity, age, obesity, sex, diet, physical inactivity, 
hypertension, lifestyle disorders and various stress factors. For alleviation and treatment there 
are many ways such as allopathic medications, alternative systems like Ayurvedic, Diet 
control, lifestyle discipline etc. Recently Spice therapies are seen useful and effective. In 
India, Ayurveda and other Indian literature mentions the use of various plants and spices. 
Spices in diet are useful as they play effective role in the functioning of various body systems 
such as gastrointestinal, cardiovascular and nervous system. Along with proper food habits, 
diet which contains variety of spices which have been proved as hypolipidemic, can be 
effective in controlling hyperlipidemia. Spices used in day-to-day life as food, can also be 
used in the treatment of various human ailments. Along with the taste, flavor, colour and 
preservative property, spices also possess hypolipidemic effects. This review is focused 
mainly on the beneficial hypolipidemic effect of five spices (Dill, Garlic, Fenugreek, Ginger, 
Coriander) in the management of hyperlipidemia. This article is based on the traditional 
knowledge, mechanism of action for hypolipidemic activity and some experimental scientific 
studies done  to support the use of these spices in the  management of hyperlipidemia. 
Introduction 
Hyperlipidemia is the main causative factor in the 
development of cardiovascular diseases like Atherosclerosis, 
Coronary Artery Disease (CAD) and many other cardiac 
conditions like Angina, Ischemic heart disease, Myocardial 
Infarction etc. It is a common disorder in developed as well as 
developing countries and is one of the main factors leading to 
Morbidity and mortality. World Health Organisation (WHO) 
reports that high blood cholesterol levels contributes to 
approximately 56% of the cases of Cardiovascular diseases 
worldwide and causes about 4.4 million deaths each year. It 
results from abnormalities in lipid metabolism or plasma lipid 
transport or a disorder in the synthesis and metabolism of 
plasma lipoproteins resulting in high level of fat in blood [1]. 
It may noticeable with the elevation of serum total 
cholesterol(TC), low-density lipoprotein (LDL), triglyceride 
(TG) concentrations, and a drop off in the high-density 
lipoprotein (HDL) concentration It may be responsible for 
oxidative modification of LDL, glucose-auto oxidation with 
excess production of free radicals and lipid peroxidation 
products[2]which represents elevated risk for ischemic heart 
diseases. The conditions like abdominal obesity, defective 
lipid metabolism are reported to be the major risk markers for 
Coronary Artery Disease (CAD). Insulin resistance develops 
because of the loss of insulin sensitivity due to the high 
concentrations of lipids in the cell. These high intracellular 
concentrations of lipid may lead to the chronic conditions like 
Diabetes Mellitus thus there is possibility of increased blood 
glucose levels. 
 
Classification of Lipids 
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The term lipids describe an entire class of fats and fat like 
substances in the blood. The most important lipids in the blood 
are fatty acids, cholesterol, cholesterol esters, Triglycerides, 
and phospholipids. Fatty acids are identified as esters of a 
long-chain monobasic organic acid, which are derived from 
fats by hydrolysis. Phospholipids (PL) are similar to the TGs 
but with one fatty acid residue replaced by phosphate and a 
nitrogenous base. 
 
Triglycerides 
Triglycerides (TGs) are esters consisting of a glycerol 
molecule coupled to three fatty acid residues of varying 
carbon chain lengths and degrees of unsaturation. TGs are 
found in dietary fats, and can also be synthesized in the liver 
and adipose tissue to provide a source of stored energy. They 
can be mobilized when required, for example, during 
starvation. TGs containing both saturated and unsaturated fatty 
acids are important components of cell membranes [3].They 
are atherogenic because they are rich in apo C-III, which 
delays the lipolysis of Very Low Density Lipoproteins and 
inhibits its uptake and Clearance from plasma. 
 
Cholesterol and cholesterol esters 
These are essential elements contained in all human cell 
membranes. Cholesterol is a structural component of steroid 
hormones and bile acids. It is present in dietary fats and can 
also be synthesized in many tissues, including liver. It is 
transported in the blood as part of large molecules called 
lipoproteins [4]. It works to build and repair cells; produces 
hormones such as estrogen and testosterone, and bile acids 
proven to aid in the digestion of fats [5].However, the high 
levels of cholesterol in the blood can cause clogging, which in 
turn can raise the risk for heart disease and/or stroke. 
Cholesterol along with some other types of fats cannot be 
dissolved in the blood. Thus in order to be transported to and 
from the cells, they have to be specially carried by molecules 
called ``lipoproteins`` 
 
 
Lipoproteins 
They are macromolecular complexes that carry hydrophilic 
plasma lipids. They are spherical particles made up of 
hundreds of lipid and protein molecules. The major lipids of 
the lipoproteins are cholesterol, TGs, and phospholipids. Five 
major lipoproteins exist, each with a different function are 
chylomicrons, VLDLs, IDLs, LDLs, and HDLs [6]. 
 
Types of lipoproteins 
 
Very Low Density Lipoproteins (VLDL) 
VLDLs are produced in the liver when Triglycerides 
production is stimulated by an increased flux of free fatty 
acids or by increased de novo synthesis of fatty acids by the 
liver. 
 
Low Density Lipoproteins (LDL) 
LDLs are made by the liver to transport cholesterol to the 
body’s cells and tissues. LDL may form deposits on the walls 
of arteries and other blood vessels. Therefore they are 
considered as the lazy or bad cholesterol. 
The main benefits of lowering LDL-C include, 
• Decreases the chance of heart attack and/or stroke. 
• Reduces the formation of new cholesterol plaques. 
• Eliminates existing plaques. 
• Prevents the rupture of existing plaques [6]. 
 
Intermediate density lipoproteins (IDL) 
IDLs are formed as TGs are removed from VLDLs. The fate 
of IDLs is either conversion to LDLs or direct uptake by the 
liver. The liver takes up IDLs after they have interacted with 
the LDL to form a complex, which is endocytosed by the cell. 
 
High Density Lipoproteins (HDL) 
HDLs pick up and transport excess cholesterol from the walls 
of arteries and bring it back to the liver for processing and 
removal. Therefore, they are called the healthy or good 
cholesterol. 
 
Table 1: Physical properties of Lipoproteins 
 
 VLDL LDL HDL 
Density 0.94-1.006 1.006-1.063 1.063-1.210 
Diameter 600 250 70-120 
Total lipid 
 (weight %) 
91 80 44 
Triacylglycerols 55 10 6 
Cholesterol esters 18 50 40 
Cholesterol 7 11 7 
Phospholipids 20 29 46 
 
 
Atherogenic index 
 
The atherogenic index of plasma (AIP), defined as the base 10 
logarithm of the ratio of plasma total cholesterol (TC) to high 
density lipoprotein cholesterol (HDL-C), has been employed 
as a predictor of cardiovascular risk. As the ratio of total 
cholesterol/HDL (TC/HDL) increases, so does the risk of 
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coronary heart disease (CHD). In populations with low CHD 
incidences, average values of TC/HDL are below 4.0.
 
Hyperlipidemia 
Hyperlipidemia is basically classified as of Primary and 
secondary type depending upon the cause of the disease in 
individual. Primary hyperlipidemia (Familial hyperlipidemia) 
is caused mainly due to the specific genetic abnormalities. 
This results from defects in the hepatic uptake and degradation 
of LDL via the down regulation of LDL -R. The latest gene 
discovered, is, PCSK9. Mutation defects of this gene causes 
hyperlipidemia. This is, the gene encoding a member of the 
proprotein convertase family. General function of PCSK9 is 
 
Table no. 1
 
   Causes   High LDL
Diabetes Mellitus 
Hypothyroidism 
Nephrotic syndrome 
Liver disease 
Renal insufficiency 
Alcoholism 
Cigarette smoking 
 
Complications due to high LDL levels in the blood
 
 
 
 
One of the complications of higher LDL concentrations in 
blood is Atherosclerosis. Atherosclerosis, or hardening of the 
arteries, is a condition in which plaque builds up inside the 
arteries. Plaque is made of cholesterol, fatty substances, 
cellular waste products, calcium and fibrin (a clotting material 
in the blood). The arterial wall becomes markedly thickened 
by these accumulating cells and surrounding material.
artery narrows and blood flow is reduced, thus decreasing the 
oxygen supply.Often a blood clot forms and blocks the artery, 
stopping the flow of blood. If the oxygen supply to the heart 
et al. / Indian J. Pharm. Biol. Res., 2015; 3(3):24-34 
 
down regulation in the LDL R pathway by causing 
degradation of LDL R protein [7]. Secondary Hyperlipidemia 
(Acquired hyperlipidemia) occurs due to the presence of other 
disorder in the body which leads to the changes or alterations 
in the plasma lipid profile or lipoprotein metabolism 
[8].Hyperlipidemia may be idiopathic. The most common 
causes are modern lifestyle habits or treatable medical 
conditions. Lifestyle habits include obesity, negligible 
physical activity, intake of high a
smoking. Medical Conditions that may lead to hyperlipidemia 
are diabetes, kidney disease, pregnancy, and hypothyroidism 
[9].This type generally needs the treatment of the causes rather 
than the treatment of hyperlipidemia.
: Causes of secondary Hyperlipidemia [1] 
-C High TG Low HDL
    
    
  - 
  - 
-   
-   
- - 
 
Fig 1: Formation of plaque 
 The 
muscle is reduced, a heart attack can occur. If the oxygen 
supply to the brain is cut off, a stroke can occur.Allopathic 
products available in the market toda
derivatives, cholesterol absorption inhibitors, bile acid 
sequestrants) are associated with many side effects like 
rhabdomylosis, hyperuricemia, nausea, myositis, gastric 
irritation, flushing , dry skin and abnormal liver funct
contraindications with other medicines[10].This creates the 
need for effective and safe drug which not only cures the 
disease but also takes care of the complex situations caused by 
26 
mount of dietary fat, and 
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y (statins, fibrates, niacin 
ion and 
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the disease. So current interest in the search of lipid lowering 
agents aims to lower the side effect profile of allopathic drugs 
and also to increase the overall efficiency of the 
treatment.Ayurvedic herbs or natural products are the 
medicinal systems considered traditional way of treating the 
diseases in India. These natural products are the combinations 
of medicinal plants which commonly occur in India and are 
inevitable part of the Indian culture. These herbal solutions are 
also well documented with the safety profile and the 
therapeutic applications for various pathological conditions. 
Hence, these medicinal products are on their way to the world 
market as alternatives to the prescribed drugs for various 
treatment conditions. At this time, most of the world 
population uses herbal medicines. The main reason behind the 
increased use of herbal remedies is the compatibility and less 
damaging nature resulting on long term use [11]. In the past 
few years, there has been tremendous growth in the field of 
herbal medicine and herbal products [12]. 
 
Spices as an alternative treatment in hyperlipidemia 
Spices are dried parts of herbs used as flavouring agents in 
cooking around the globe owing to their taste and aroma. 
Spices are the common dietary adjuncts that contribute to the 
taste and flavor of foods. Balanced diet has always been 
recognized as a basis in the management of hyperlipidemia. 
Since ancient times, various herbs and spices are being used to 
treat hyperlipidemia. Scientific investigations have confirmed 
the effectiveness of these herbs spices. Besides spices, are also 
known to exert several beneficial physiological effects [13].  
Spices supplements and diet-based therapies for weight loss 
are among the most common complementary and alternative 
medicine (CAM) modalities.A vast range of these natural 
products and medicinal plants, including crude extracts and 
isolated compounds from plants. They can be used to induce 
weight loss and prevent diet-induced obesity. In the recent 
decades, these have been vastly used in management of 
obesity.Due to the presence of large variety of components 
with different anti-obesity and anti-oxidant effects on body 
metabolism and fat oxidation.This article gives brief overview 
of the five common spices that are routinely used in diet all 
over india. 
 
Anethum graveolans                                                    
Table no. 2: Classification of Dill 
 
 
 
 
 
 
Anethum graveolens L. known as dill is a sparse looking plant 
with feathery leaves and tiny yellow flowers growing in the 
Mediterranean region, Europe, central and southern Asia and 
is widely cultured in south eastern region of Iran [14]. 
Phytoconstituents: Anethum graveolens contain 1 - 4% 
essential oil comprising of major compounds: carvone (30 - 
60%), limonene (33%), α-phellandrene (20.61%), including 
pinene, diterpene, dihydrocarvone, cineole, myrcene, 
paramyrcene, dillapiole, isomyristicin, myristicin, myristin, 
apiol and dillapiol. Anethum graveolens also contains 
essential oil, furanocoumarin, 5-(4”-hydroxy-3”methyl-2”- 
butenyloxy)-6, 7- furocoumarin, oxypeucedanin, 
oxypeucedanin hydrate and falcarindiol. 
Uses: As a folk remedy Anethum graveolens or dill is 
considered for some gastrointestinal ailments such as 
flatulence, indigestion, stomachache and in traditional Iranian 
medicine (TIM), it has been used as carminative, 
antispasmodic, sedative, galactagogue, diuretic and for 
hyperlipidemia [15]. Pharmacological effects of dill such as 
anti-inflammatory, antimicrobial, or antibacterial, anti 
hyperlipidaemic, anti hypercholesterolaemic , antioxidative 
and hypoglycemic  activities have been shown[16]. 
 
Mechanism of action: Possible explanations for 
hypolipidemic effects of the Anethum graveolens included 
that this compound could inhibit carbohydrate absorption and 
metabolism [17]. The cholesterol lowering effect of the plant 
extract is possibly associated with a decrease in intestinal 
absorption of cholesterol resulting in an increase in fecal 
excretion of neutral lipids [18]. Improvement in the biological 
antioxidant status by reducing lipid peroxidation in liver and 
modulating the activities of antioxidant enzymes is another 
mechanism for dill acting as hypolipidemic [19]. 
 
Hypolipidemic studies reported 
Ali esmail al-snafi have reported the anti-hyper 
cholesterolaemic and anti-hyperlipidaemic activities of crude 
extract of Anethum graveolens. Treatment with defatted 
ethanolic Anethum graveolens extract to hyperlipidemic rats 
for 30 days showed significant increase in 
HMGCoA/mevalonate ratio [19]. 
Kingdom Plantae 
Phylum Angiosperms 
Subphylum Eudicots 
Class Asterids 
Order Apiales 
Family Apiaceae 
Genus Anethum L 
Species Anethum Graveolens 
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Mansouri et al have proved the significant reduction in TG 
levels from baseline in 12 weeks on administration of Dill 
extract [20]. 
Ahmed Salih Sahib et al have studied the effect of Dill leaves 
powder on hyperlipidemic patients for duration of 4 weeks. 
The pre-treatment values of serum lipids for both treatment 
groups were significantly (P≤0.05) higher than that of control, 
except that of HDL-C which was non-significantly lower than 
control. Post treatment values resulted in highly significant 
reduction of TC, TG, LDL-C and VLDL-C, at 95% 
confidence level. Dill extract was considered safe and 
tolerable as no side effects were reported during the study 
[21].Hermansen et al have proved the beneficial modulatory 
influence of dill extract on cholesterol metabolism.  
Administration of alkaloid compound A of Anethum 
graveolens extract caused a significant decrease in serum total 
cholesterol, LDL-cholesterol, VLDL-cholesterol. Extract 
treated rabbits showed decrease in the ratio of total cholesterol 
/ HDL-cholesterol and LDL-cholesterol / HDL-cholesterol .It 
might be a consequence of higher proportion of HDL-
cholesterol which reduced atherogenic index by increased 
transport of cholesterol from peripheral organs to liver [22]. A 
significant decline in the serum triglycerides level observed in 
plant extract treated rabbits supporting the cardiovascular 
protective influence. Mirhosseini M have reported 18% 
reduction in the mean level of cholesterol as compared to that 
of the Gemfibrozil group which showed  reduction of upto 
9.41%(P < 0.05) on administration of Dill . Gemfibrozil and 
Dill has shown reduction in triglyceride by 32.7% and 7.38%, 
respectively (P < 0.05). Increased HDL –C level was observed 
in Gemfibrozil ( 3.91%) , as compared to reduction by Dill 
(0.8%). However, 21.4% of patients who used gemfibrozil 
reported gastrointestinal complications whereas Dill treated 
patients did not report any signs of adverse effects [23]. 
 
Alium sativum                                                            
Table no. 3: Classification of Garlic 
 
 
 
 
 
 
 
 
 
 
 
Allium Sativum (Lat.), (Eng: Garlic, Urdu: ‘Lahsan’) 
commonly known as garlic, is a species in the onion genus. It 
is native to central Asia, and has long been used a food 
ingredient in the Mediterranean region, as well as a frequent 
seasoning in Asia, Africa, and Europe.  
Phytoconstituents: Garlic contains at least 33 sulfur 
compounds like aliin, allicin, ajoene, allylpropl, diallyl, 
trisulfide, s-allylcysteine, vinyldithiines, S-
allylmercaptocystein, and others. Besides sulfur compounds 
garlic contains 17 amino acids and their glycosides, arginine 
and others.  
Uses: It is used not only as spice but also as a popular remedy 
for prevention and treatment of a variety of diseases like 
rheumatism, dermatitis, abdominal disorders and diabetes 
mellitus. It has natriuretic and diuretic effects, antiplatelet and 
fibrinolytic, cardioprotective effects have also been reported. 
Mechanism of action: Human study report suggests that,, the 
active principle of garlic against hyperlipidemia is the 
essential oil, which contains a combination of sulphur-
containing compounds, mainly allyl propyl disulphide and 
diallyl disulphide. The lipid-lowering effect of Garlic may 
occur via inhibition of HMG-CoA reductase or other enzymes, 
possibly by diallyl di- and trisulphide components of garlic. 
Other suggested mechanisms include increased loss of bile 
salts in feces and mobilization of tissue lipids into 
circulation.Scientists have also suggested that garlic may act 
by increasing the excretion of cholesterol end products and by 
affecting it's synthesis in the liver. Aqueous garlic extract also 
made the LDL significantly resistant to oxidation, it may be 
one of the powerful mechanism accounted for the benefits of 
garlic in atherosclerosis [24]. 
Hypolipidemic studies reported: Raghuveer Choudhary have 
studied the  benificial effect of Allium Sativum and Allium 
Tuberosum on experimental hyperlipidemia and 
atherosclerosis. Both the species of garlic produced significant 
reduction in serum cholesterol, triglycerides, LDL-C and 
atherogenic index by 95% confidence interval as compared to 
control group. There was no significant increase in HDL-C. 
Garlic also prevents fall of HDL, which is nonatherogenic and 
transfers cholesterol from the periphery to the liver [25].Effect 
of garlic in cardiovascular diseases was found to be more 
encouraging in experimental studies, which led to conduct of 
several clinical trials. Since 1993, data of 25 clinical trials 
have been published that have investigated the hypolipidemic 
effects of garlic .Out of 25, 11 studies have been successfully 
proven the reduction in serum cholesterol [26]. A systematic 
Kingdom Plantae 
Phylum Angiosperms 
Class monocots 
Order Asparagales 
Family Amaryllidaceae 
Subfamily Allioideae 
Genus Allium 
Species Allium sativum 
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review of the effectiveness of garlic as an antihyperlipidemic 
agent was published in 2003 included 10 studies and found 
that in 6 studies garlic was effective in reducing serum 
cholesterol levels. The average fall in total cholesterol was 
9.9%, LDL 11.4%, and triglycerides 9.9% [26]. Earlier meta 
analysis has confirmed that garlic is superior to a placebo in 
reducing total cholesterol levels [27].Khalid Rahman et al 
have performed in vitro study inidicating inhibition of 
enzymes involved in cholesterol and fatty acid synthesis by 
Garlic and its constituents. The studies were carried out in 
cultured rat hepatocytes and human HepG2 cells. Final 
measurements of enzyme activity showed that garlic and its 
constituents inhibit human squalene mono oxygenase and 
HMG-CoA reductase, which are enzymes involved in 
cholesterol biosynthesis. It has also been shown that the more 
water-soluble compounds like S-allylcysteine (SAC), 
sethylcysteine, and S-propylcystein present in aged garlic 
extract are less cytotoxic and more efficient in inhibiting 
cholesterol biosynthesis than the lipid-soluble sulfur 
compounds such as diallyl sulfide (DAS) [28]. 
 Md.Asaduzzaman et al have proved the Pet ether, ethyl 
acetate and chloroform fractions of the Alium sativum to be 
hypolipidemic as they showed reduction in total cholesterol 
upto 51.2%, 30.4%, 29.9% respectively. 
Mechanism proposed for the lipid lowering activity of this 
extract was the inhibition of the enzyme hydroxyl methyl 
glutaryl Co-A reductase, which participates in De-Novo 
cholesterol synthesis [29]. 
Prema Ram Choudhary et al have studied the effect of 
aqueous and alcoholic extracts of garlic for hypolipidemic 
activity. In the study, a significant reduction in the serum 
cholesterol, serum triglyceride, LDL-C, VLDL-C and 
atherogenic index in hyperlipidemic guinea pigs (p<0.001) 
was observed as compared to control group. On comparison 
between the two extracts, aqueous extract of garlic was found 
to be more potent hypolipidemic agent than the alcoholic 
extract [30]. 
 
 
Fenugreek                                                               
 
Table no. 4: Classification of Fenugreek 
 
 
 
 
 
 
Fenugreek (Trigonellafoenum-graecum) is known as ‘Methi’ 
in Hindi and commonly used as a spice in cooking. Fenugreek 
is cultivated in India, Egypt, Middle East and North Africa.  
Phytoconstituents: Major active compound of fenugreek is 
Diosgenin, a steroid sapogenin. Other sapogenins found in 
fenugreek seed include yamogenin, gitogenin, tigogenin, and 
neotigogens. Fenugreek seeds also contain alkaloids, including 
trigonelline, gentianine and carpaine compounds. The seeds 
also contain fiber, 4-hydroxyisoleucine and fenugreekine. 
Uses: The seeds of the plant have been used as a traditional 
remedy for conditions including gastrointestinal disorders, 
gout, inflammation, hyperlipidemia and diabetes. Fenugreek 
seeds are used for their wound healing, carminative, tonic and 
aphrodisiac effects. 
Mechanism of action: Fecal bile acid and cholesterol 
excretion are increased by fenugreek  administration. 
Fenugreek also contains a biologically significant level of 
saponins [31].Cholesterol excretion may be secondary to a 
reaction between the bile acids and fenugreek-derived 
saponins causing the formation of micelles too large for the 
digestive tract to absorb. Another theory suggests the 
cholesterol lowering activities to the fiber-rich gum portion of 
the seed that reduces the rate of hepatic synthesis of 
cholesterol. The soluble fiber from fenugreek appears to 
decrease reabsorption of bile acids in the small intestine 
increasing the excretion of cholesterol and bile acids into the 
feces. Consequently, the need of cholesterol for bile acid 
biosynthesis is enhanced and blood cholesterol concentrations 
are reduced [32]. It is likely that both mechanisms contribute 
to the overall effect [33].  
Hypolipidemic studies reported:Saxena B.et al evaluated 
lipid lowering effect of fenugreek seed extract in Triton and 
high fat diet induced hyperlipidemic models of albino rats. 
Aqueous seed extract of fenugreek (120 mg/kg,) inhibited the 
elevation in plasma cholesterol in Triton administrated rats. 
The aqueous seed extract at the same dose level significantly 
attenuated the plasma total cholesterol, triglycerides, 
lipoprotein cholesterol (HDL, LDL and VLDL) in high-fat 
diet-induced hyperlipidemic rats. It also found to improve the 
atherogenic index (AI) in high fat diet model [34]. 
Sharma et al investigated 15 non-obese, asymptomatic, 
hyperlipidemic adults. After intake of 100 gm fenugreek 
powder per day for three weeks, the subjects showed a 
reduction in their triglyceride (TG) and Low density 
Kingdom Plantae 
Phylum Angiosperms 
Subphylum Eudicots 
Class Rosids 
Order Fabales 
Family Fabaceae 
Genus Trigonella 
Species T.FoenumGraecum 
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Lipoprotein cholesterol (LDL-C) levels as compared with 
baseline values. Slight decrease in high density lipoprotein 
(HDL) levels were also noted [35].  
M. Al-Habori  et al have demonstrated the effect of fenugreek 
on plasma lipid levels when given along with the high fat diet. 
This Experiment clearly showed the plasma cholesterol and 
triglyceride values of rabbits fed on diets 20%, 30% and 60% 
were lower than the group with high fat diet (p < 0.01). There 
was no effect on the HDL-cholesterol. None of the diets 
containing fenugreek had any significant effect on the body 
weight gain relative to the control group [36].Sowmya and 
Rajyalakshmi observed significant reductions in total 
cholesterol and low density lipoprotein cholesterol (LDL-C) 
levels in 20 adults with hypercholesterolemia who received 
12.5- 18.0 gm powdered, germinated fenugreek seeds for one 
month [37]. Abu Saleh M et al have undertaken the study to 
demonstrate the effect of fenugreek seed powder on lipid 
profile in hyper-lipidemic Type 2 diabetic patients. The 
fenugreek seed powder significantly (p < 0.001) reduced 
serum total cholesterol, serum triacylglyceride level and serum 
LDL-cholesterol level in hyperlipidemic Type 2 diabetic 
patients. The serum HDL-cholesterol level increased but not 
significantly by the fenugreek seed powder. No significant 
changes found in control group i.e. hyperlipidemic patients not 
taking fenugreek [38]. 
 
Ginger                                                                      
 
Table no. 5: Classification of Ginger 
 
 
 
 
 
 
 
 
 
 
 
Ginger (Zingiber officinale Roscoe, family Zingiberacae) is a 
herbaceous perennial comprising a rhizome, fibrous roots and 
aerial shoots . It is cultivated extensively across India, 
Southeast Asia, tropical Africa, Pacific Ocean islands and 
Australia. 
Phytoconstituents :Ginger contains essential oils including 
gingerol and zingiberene. It also contains pungent principles 
such as zingerone, gingerol and shogaol 
Uses: It has been widely used in Chinese, Ayurvedic and 
Unani herbal medicines all over the world for the treatment of 
arthritis, rheumatism, sprains, muscular aches, pains, sore 
throats, cramps, constipation,  indigestion, vomiting, 
hypertension, dementia, fever, infectious diseases and 
helminthiasis. 
Mechanism of action: The plasma lipid lowering effect of 
Ginger extract is possibly associated with several processes, 
including disruption of cholesterol absorption from the GI 
tract [39].and interference with cholesterol biosynthesis in 
liver [42]. Literature suggests that ginger contains antioxidant 
properties are hypocholesterolemic and anti-atherogenic, and 
these activities might be attributed to the inhibition of LDL 
oxidation and the suppression on the activity of HMG-CoA (3-
hydroxy- 3methyglutaryl co-enzyme A) reductase [40]. This 
also might occur due to the elevation of hepatic cholesterol 7-
alpha-hydroxylase activity, which is a rate-limiting enzyme in 
the biosynthesis of the bile acids and stimulates the conversion 
of cholesterol to bile acids leading to the excretion of 
cholesterol from the body [41]. 
Hypolipidemic studies reported: P.Paul et al have evaluated 
the hypolipidemic effect of ginger in vanaspati(Hydrogenated 
vegetable fat) fed rats. The total cholesterol, LDL-C, 
triglycerides levels were found to be increased by the 
administration of vanaspati whereas HDL-C level was found 
to be decreased significantly (p<0.05). Simultaneous 
administration of ginger extract reversed the effect 
significantly (p<0.05). No significant changes in liver were 
found in histopathological study [43].U Bhandari et al have 
studied the effects of ethanolic extract of ginger (200 mg/kg). 
The increased serum and tissue cholesterol, serum 
triglycerides, serum lipoproteins and phospholipids due to 70 
days of cholesterol feeding, was significantly reduced by the 
administration of the ethanolic ginger extract and results were 
compared with gemfibrozil. The test drug and standard drug 
significantly (P< 0.01) reduced the levels of serum and tissue 
cholesterol, serum triglycerides, LDL+VLDL-C, serum 
phospholipids and increased HDL-C levels when compared 
with pathogenic group. Animals receiving ginger extract along 
with cholesterol also showed a lower degree of atherosclerosis 
[44]. Abd-Elraheem A. Elshater  et al investigated  the effects 
of daily oral administration of ginger extract for 60 days on 
plasma glucose, lipid profile and kidney functions in alloxan-
induced diabetic rats.The treatment with ginger extract 
reduced plasma cholesterol, triglyceride and LDL-cholesterol, 
but the pre-treatment with ginger extract produced 
insignificant change only in plasma triglyceride level. The 
plasma HDLcholesterol was significantly increased in post-
treated and pre-treated groups [45]. 
Kingdom Plantae 
Phylum Angiosperms 
Subphylum Monocots 
Class Commelidins 
Order Zingibareles 
Family zingiberaceae 
Genus Zingiber 
Species Zingiberofficinale 
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Reza Alizadeh-Navaei et al carried out double blind controlled 
clinical trial study to investigate hypolipidemic effect of 
ginger in 85 human individuals. There was a significant 
decrease (p<0.05) in triglyceride, cholesterol, low density 
lipoprotein (LDL), very low density lipoprotein (VLDL) 
levels of before and after study separately in each group. Mean 
changes in triglyceride and cholesterol levels of ginger group 
were significantly higher than placebo group (p<0.05). Mean 
reduction in LDL level and increase in high density 
lipoprotein level of ginger group were higher than the placebo 
group, but in VLDL level of placebo was higher than ginger 
(p>0.05) [46].  
Zainab M et al have studied the effect of an aqueous extract of 
raw ginger on Streptozotocin (STZ)-induced diabetic rats. The 
aqueous extract was administered daily (500 mg/kg ip) for a 
period of 70 days. At a dose of 500 mg/kg, raw ginger was 
significantly effective in lowering serum glucose, cholesterol 
and triacylglycerol levels in the ginger-treated diabetic rats 
compared with the control diabetic rats. After treatment, the 
serum cholesterol levels of ginger-treated diabetic rats 
significantly decreased by 44% in comparison with control 
diabetic rats. A significant reduction of 41% in serum 
triacylglycerol levels was observed  during the 7 weeks of 
treatment. In contrast, the serum cholesterol and 
triacylglycerol levels were elevated in the control diabetic 
group throughout the experimental period [47].  
 
 
Coriander                                                              
 
Table no. 6: Classification of coriander 
 
 
 
 
 
 
 
 
 
 
 
Coriander,(Coriandrum sativum) also known as Cilantro, 
dhania or Chinese parsley ,  is an annual herb belonging to the 
family Apiaceae. Coriander is native to regions spanning from 
southern Europe and North Africa to south west Asia. 
Phytoconstituents: The seed of Coriandrum sativum contain 
0.5-1% essential oil which is rich in beneficial phytonnutrients 
including carvone, geraniol, limonene, borneol, camphor, 
elemol and linalool. The flavonoides present in Coriander  
include quercitin, kaempferol, rhamentin and apigenin. It also 
contains active phenolicacid compounds including caffeic and 
cholorogenic acid. 
Uses:The health benefits of coriander include its use in the 
treatment of skin inflammation, high cholesterol levels, 
diarrhoea, mouth ulcers, anemia, indigestion, menstrual 
disorders, small pox, conjunctivitis, skin disorders, and blood 
sugar disorders, while also benefiting eye care. 
Mechanism of action:Coriander enhances the Bile acid 
synthesis and increases the degradation of cholesterol to fecal 
bile acids and neutral sterols. Hence coriander can reduce high 
levels of lipid in the body by increasing their metabolism and 
eventual excretion. The coriander oil also reduces the activity 
of the enzyme HMG-CoA which is the key regulatory enzyme 
in cholesterol synthesis. As a result, significant hypolipidemic 
effect of coriander oil is observed [48].  
Hypolipidemic studies reported:Sam lal et al have 
demonstrated the effect of coriander in the biphasic model of 
Triton induced hyperlipidemia in rats.  Coriander at a dose of 
1gm/kg body weight, proved to reduce cholesterol and 
triglycerides level in both synthesis and excretory phases in 
rats and the results were comparable with that of the Liponil, a 
commercially available hypolipidemic agent [49]. Essa H. Al-
Mashhadani et al have conducted the study to investigate the 
potential effect of coriander oil on 135 day old broiler chicks 
for 42 days. Chicks were randomly assigned in to three dietary 
treatments with three replicate pens per treatment. Birds were 
fed on diets containing 0, 0.5 and 1% coriander oil. Results 
showed that the inclusion of coriander oil at levels of 0.5% 
and 1% significantly (p<0.05) decreased plasma cholesterol 
and glucose. Increased HDL-C level was also observed [50]. 
Ullagaddi Rajeshwari  et al have carried out comparison of 
aniseeds and coriander seeds for antidiabetic, hypolipidemic 
and antioxidant activities. Significant decrease in serum 
cholesterol and triglycerides upto 15% and 30% respectively 
was observed in coriander seed-treated Type 2 diabetics 
respectively was observed at final stages of the experiment. 
No significant change was observed with respect to VLDL, 
LDL and HDL-C in control group where as significant 
decrease of 31% (p<0.001) in VLDL –C and 9% (P<0.001) in 
LDL-C was noticed respectively in group treated with 
coriander seeds. Also, 42% (P<0.001) increase was observed 
in HDL-C levels in the coriander treated group. With respect 
to VLDL-C, LDL-C and HDL-C, treatment with coriander 
was found to be better compared to that of aniseeds treatment 
[51]. 
Kingdom Plantae 
Phylum Angiosperms 
Subphylum Eudicots 
Class Asterids 
Order Apiales 
Family Apeaceae 
Genus Coriandrum 
Species C.Sativum 
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Chitra V et al have studied the effect of the administration of 
coriander seeds on the metabolism of lipids in rats fed a high 
fat diet with added cholesterol. The spice was proven to have a 
significant hypolipidemic action. The levels of total 
cholesterol and triglycerides decreased significantly in the 
tissues of the animals of the experimental group which 
received coriander seeds. Significant increases in beta-
hydroxy, beta-methyl glutaryl CoA reductase and plasma 
lecithin cholesterol acyl transferase activity were noted in the 
experimental group. The level of LDL and VLDL cholesterol 
decreased while that of HDL cholesterol increased in the 
experimental group compared to the control group [52]. 
 
Conclusion 
 
Spices are dietary supplementary herbs used widely in Indian 
foods as flavouring agent, colouring agent and preservative 
from thousands of years. There available is ancient literature 
which reveal significance of these spices, their uses, 
cultivations, economical aspects. The proven efficacy of the 
actives in these spices have led to their pharmacological 
applications in the indigenous system of medicine all over the 
world. The research envisaged about the active 
phytochemicals derived from these spices have reached upto 
the molecular level giving the actual mechanism of actions of 
the herbs. Numerous studies have been carried out in past few 
decades which proved digestive stimulatory, anti-
inflammatory, antioxidant, anti diabetic, hypolipidemic, anti 
mutagenic actions of a range of spices, proving the safety and 
efficacy of herbal medicines. Thus, India ‘the house of spices’ 
is having wide scope of development and opportunity to assess 
the spice therapy as alternative and complementary in the 
treatment of hyperlipidemia. At present, there is availability of 
the satisfactory data on the basis of which we can support the 
consumption of food rich in spices for the management of 
hyperlipidemia. In future, we can expect more bulk of the 
scientific evidence supporting the benefits of herbs and spices 
in the overall maintenance of health and protection from 
disease. Inclusion of these herbs and spices cannot only satisfy 
Culinary but also improve desired quality of life. 
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